The cuts are part of a purge of 5,200 probationary workers across federal health agencies that started Friday.

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure TrialAchieve Reiterates Planned Cytisinicline NDA Submission in Q2 ...

The FDA published it three days later, on the 28th. The recalled products include 8-ounce packages of La Fiesta brand "Unseasoned Bread Crumbs (Pan Rayado)" and "Seasoned Bread Crumbs (Pan Rayado ...

LEVERKUSEN, Germany (AP) — Bayer Leverkusen has signed Argentine offensive midfielder Emiliano Buendia on loan from Aston Villa to compensate for the injured Martin Terrier. The defending ...

Drug firm Laurus Labs Ltd on Wednesday (January 22) said its wholly-owned foreign subsidiary Laurus Generics Inc (LGI), based in Berkeley Heights, New Jersey, has received a Form 483 from the US Food ...

Not all chemical hair relaxers include the chemical, but many include ingredients that can release formaldehyde when heated, the FDA said in 2024. Over the years, an increasing number of studies ...

However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Specifically, the change would add the selection to field D5 of FDA Forms 3500 and 3500A, which currently include options for only over-the-counter, generic, compounded and biosimilar drugs. It would ...